EverSource Wealth Advisors LLC boosted its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Free Report) by 83.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,312 shares of the pharmacy operator’s stock after buying an additional 2,422 shares during the period. EverSource Wealth Advisors LLC’s holdings in Walgreens Boots Alliance were worth $50,000 as of its most recent SEC filing.
Several other institutional investors have also recently bought and sold shares of WBA. State Street Corp raised its holdings in Walgreens Boots Alliance by 18.0% during the third quarter. State Street Corp now owns 42,997,580 shares of the pharmacy operator’s stock worth $385,258,000 after buying an additional 6,569,223 shares during the last quarter. Charles Schwab Investment Management Inc. raised its holdings in Walgreens Boots Alliance by 43.6% during the third quarter. Charles Schwab Investment Management Inc. now owns 10,969,188 shares of the pharmacy operator’s stock worth $98,284,000 after buying an additional 3,329,857 shares during the last quarter. Two Sigma Advisers LP bought a new stake in shares of Walgreens Boots Alliance in the 3rd quarter worth $24,226,000. Amundi grew its stake in shares of Walgreens Boots Alliance by 70.3% in the 4th quarter. Amundi now owns 4,455,720 shares of the pharmacy operator’s stock worth $41,082,000 after acquiring an additional 1,839,045 shares in the last quarter. Finally, Raymond James Financial Inc. bought a new stake in shares of Walgreens Boots Alliance in the 4th quarter worth $9,685,000. Institutional investors and hedge funds own 58.59% of the company’s stock.
Analyst Ratings Changes
WBA has been the subject of several recent analyst reports. Deutsche Bank Aktiengesellschaft lowered shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating and reduced their target price for the stock from $11.00 to $9.00 in a research note on Friday, February 28th. Evercore ISI upped their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a research note on Monday, January 13th. StockNews.com initiated coverage on shares of Walgreens Boots Alliance in a research note on Tuesday. They issued a “hold” rating for the company. Wolfe Research upgraded shares of Walgreens Boots Alliance to a “hold” rating in a research report on Monday, February 24th. Finally, Royal Bank of Canada increased their price target on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a research report on Wednesday, January 15th. Four investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $10.59.
Walgreens Boots Alliance Price Performance
Shares of NASDAQ:WBA opened at $11.16 on Thursday. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68. The firm has a market capitalization of $9.64 billion, a PE ratio of -1.09, a P/E/G ratio of 1.31 and a beta of 0.62. Walgreens Boots Alliance, Inc. has a twelve month low of $8.08 and a twelve month high of $22.05. The company has a 50-day moving average price of $10.93 and a two-hundred day moving average price of $9.80.
Walgreens Boots Alliance (NASDAQ:WBA – Get Free Report) last issued its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, topping analysts’ consensus estimates of $0.38 by $0.13. The firm had revenue of $39.50 billion during the quarter, compared to analyst estimates of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The company’s quarterly revenue was up 7.6% on a year-over-year basis. During the same quarter last year, the business earned $0.66 earnings per share. Equities analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
Featured Stories
- Five stocks we like better than Walgreens Boots Alliance
- What is the FTSE 100 index?
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- How to Most Effectively Use the MarketBeat Earnings Screener
- Alphabet’s Officially In A Bear Market—Time To Buy?
- How to invest in marijuana stocks in 7 steps
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.